Why Is Lupus Named After a Wolf?

Lupus takes its name from the Latin word for wolf, but the reason is not what most people assume. The popular explanation holds that the facial sores characteristic of the disease look like a wolf bite, yet the earliest medical writers who adopted the term were reaching for a different image: skin lesions that devoured flesh the way a hungry wolf devours prey. The name has stuck for roughly a thousand years, accumulating additional folk explanations along the way, and the disease it describes has been radically redefined since the Middle Ages.

The Oldest Known Uses of the Name

Pinning down who first called a disease “lupus” turns out to be surprisingly difficult. A 2024 study tracing the term’s origin identified three candidates for the earliest recorded use. One is an affidavit written in 963 AD by Eraclius, Bishop of Liège in modern-day Belgium. Another appears in a twelfth-century historical account of the same bishopric, long misattributed to a ninth-century bishop named Herbernus. The third is a 1170 letter by Pierre de Blois describing the death of Archbishop Stephan du Perche.¹ All three instances are non-medical documents that use “lupus” to describe severe, potentially fatal skin conditions, but none of them are clinical texts.

The first use in an actual medical book came later, in 1230, when the Italian surgeon Rolandus (Rolando da Parma) included the term in a surgical treatise.¹ By then the word had already been circulating for centuries in non-medical writing. Medieval European physicians, when they finally adopted it, were inheriting a label that had been shaped by religious scribes and letter-writers, not clinicians.

The Devouring Wolf, Not the Wolf Bite

You will find the “wolf bite” explanation repeated in textbooks, patient resources, and even some peer-reviewed articles. The idea is that ulcerative facial sores reminded medieval observers of wounds left by a wolf’s teeth. A separate, overlapping theory suggests the reddish butterfly-shaped rash across the cheeks and nose resembles the facial markings of a wolf.² Both of these explanations sound plausible, and both have been passed along for generations.

The problem is that the earliest sources do not describe a resemblance to a wolf’s bite or face. When Rolandus and the non-medical writers before him used “lupus,” they were describing lesions that ate away at the skin and underlying tissue, consuming flesh the way a wolf consumes its prey. The metaphor was about destruction, not appearance. As the 2024 etymological study puts it, the term was applied to “potentially deadly skin lesions that devoured the affected person’s skin and internal matter.”¹

This distinction matters more than it might seem. Medieval “lupus” was a catch-all for any aggressive, tissue-destroying facial lesion, including what we now recognize as skin tuberculosis, cancerous tumors, and various ulcerating infections. The wolf metaphor captured the voraciousness of the destruction, not the shape of the wound. The bite-mark story likely arose later, as a post-hoc rationalization once people had forgotten the original usage.

Animal Names in Skin Disease Are Surprisingly Common

Lupus is not the only dermatological condition named after an animal. Medical terminology is peppered with zoological labels: conditions compared to fish scales, butterfly wings, spider veins, and more. These “animal eponyms” served as quick mental shorthand for physicians who lacked laboratory diagnostics and relied instead on what a lesion looked like, felt like, or behaved like.³ In that context, calling a flesh-eating lesion a “wolf” was no stranger than any of the other animal comparisons medieval and early modern physicians reached for. The wolf was simply the most fearsome predator available as a metaphor for a condition that left patients disfigured or dead.

How “Lupus” Went from Skin Ulcer to Autoimmune Disease

For about six hundred years after Rolandus, “lupus” remained a dermatological label slapped onto a grab bag of different conditions. The word was doing the work of a symptom description, not a diagnosis. Physicians used it whenever they saw tissue being progressively destroyed on a patient’s face, regardless of the underlying cause.

The real turning point came at the start of the nineteenth century, when physicians began sorting out the differences between lupus vulgaris, the skin form of tuberculosis, and cutaneous lupus in its modern sense.⁴ Separating lupus from tuberculosis was a slow and difficult process. Both conditions could eat away at the face, both could leave deep scars, and before the identification of the tuberculosis bacterium in 1882, there was no easy way to tell them apart at the bedside.

The French dermatologist Pierre Cazenave is often credited with producing the first detailed, accurate clinical description of lupus as a distinct disease entity, a project that evolved over his sixty-year career.⁵ Cazenave also gave the disease the fuller name “lupus erythematosus,” adding the Latin word for reddened, which reflected the inflamed, flushed appearance of the lesions he was studying rather than the deep ulcers the medieval writers had been describing.

The shift from skin disease to systemic illness took another half-century. Between 1895 and 1904, the Canadian physician William Osler published a series of cases showing that what had been classified as a skin condition could come with joint pain, kidney problems, and other organ involvement.⁶ Osler’s contribution is sometimes overstated, and historians have argued that most of his reported cases were actually other diseases. But his core insight, that skin manifestations could be the visible tip of a body-wide process, pointed the field toward what we now call systemic lupus erythematosus, or SLE.

What Lupus Actually Is, in Modern Terms

The disease that carries the medieval wolf name is nothing like what medieval physicians were treating. SLE is a systemic autoimmune condition in which the immune system produces antibodies against the body’s own cell components, especially proteins in the cell nucleus. These self-targeting antibodies form clumps called immune complexes that can deposit in the kidneys, blood vessels, joints, and skin, causing inflammation and tissue damage.⁷

At the molecular level, a key driver of the disease is a family of signaling molecules called type I interferons. These are proteins the body normally releases to fight viral infections, but in people with SLE, they are overactive. Genetic variants that ramp up this signaling pathway have been linked to disease risk, and the resulting chronic immune activation helps explain why SLE can flare up unpredictably and affect nearly every organ system.⁸ Researchers have suspected this interferon connection for decades, and it has increasingly become a target for newer therapies.⁹

None of this was remotely imaginable when medieval scribes started calling flesh-eating skin lesions “wolves.” The name is an artifact of a time when doctors classified disease by what it looked like on the outside, and it has survived mostly because medicine tends to keep its old labels even when the understanding underneath has been completely overhauled.

The Butterfly Rash and the Second Wolf Theory

The malar rash, the reddish eruption that spreads across both cheeks and the bridge of the nose in a butterfly-wing pattern, is probably the most recognizable visible sign of SLE. This rash has inspired its own separate wolf-related explanation: that the pattern looks like the markings on a wolf’s face. Some authors have proposed that the original naming had nothing to do with devouring and everything to do with this visual resemblance.²

The trouble with this theory is chronological. The butterfly rash is a hallmark of SLE as we understand it today, but the medieval writers using the term “lupus” were describing deep, tissue-destroying ulcers, not a flat, reddish rash. The malar rash was not distinguished as a separate sign of lupus erythematosus until the nineteenth century, long after the wolf metaphor had become established. It is more likely that the wolf-face explanation is another layer of retrofitted storytelling, an attempt to make the name fit the modern disease rather than the medieval one.

How Modern Classification Works

The name may be ancient, but the diagnostic framework is thoroughly modern. The current standard for classifying SLE, published jointly by the European and American rheumatology associations in 2019, requires a positive test for antinuclear antibodies as a mandatory first step. After that, patients are evaluated across seven clinical domains and three immunological domains, each weighted by severity. A score of 10 or more points leads to a classification of SLE. In validation testing, these criteria had a sensitivity above 96% and a specificity above 93%.¹⁰

The gap between a name rooted in medieval visual metaphor and a classification system built on weighted immunological criteria is about as wide as medicine gets. Patients diagnosed today are identified by blood markers and organ-system scoring, not by whether their skin looks like it has been gnawed by an animal.

Why Lupus Overwhelmingly Affects Women

One of the most striking features of SLE is its sex skew: roughly nine out of ten patients are women. For a long time the assumption was that female sex hormones, especially estrogen, were the main explanation. Estrogen does play a role. In mouse models, estrogen enhances the production of the self-targeting antibodies that drive lupus, but only in genetically susceptible females.¹¹

The more surprising discovery is that the X chromosome itself contributes to disease risk independently of hormones. Researchers created mice that had either XX or XY chromosomes, regardless of whether they had ovaries or testes. The XX mice were consistently more susceptible to lupus-like disease, no matter which gonads they carried. In humans, the pattern holds: men with Klinefelter syndrome, who carry an extra X chromosome, develop lupus at roughly 14 times the rate of typical men, putting them on par with women. Women with triple X syndrome show about 2.5 times the lupus risk of women with the usual two X chromosomes, while women with Turner syndrome, who have only one X, are at lower risk.¹²

The implication is that the number of X chromosomes creates a dosage effect. More X chromosomes mean more copies of certain immune-related genes on the X, which in turn means a greater chance of immune dysregulation. Hormones push the odds further, but they are not the whole story.

Sunlight as a Trigger

Ultraviolet light is one of the best-documented environmental triggers for lupus flares, particularly in the skin. UV exposure damages skin cells, causing them to die and release their contents. In someone with lupus, the immune system overreacts to this debris. The dying cells release chemical signals that recruit more immune cells to the area, which release more inflammatory signals, which recruit still more immune cells, creating a self-amplifying loop that drives the characteristic skin lesions of cutaneous lupus.¹³ This is why sun protection is among the most basic and most important pieces of advice given to lupus patients, and why many people with SLE report that their symptoms worsen in summer or after time outdoors.

Wolves Can Get It Too (Sort Of)

There is an irony buried in the name: wolves’ closest domesticated relatives, dogs, are among the non-human animals most commonly diagnosed with SLE. Canine systemic lupus erythematosus was first described in the 1960s, when researchers documented a naturally occurring immune disorder in dogs characterized by autoimmune hemolytic anemia, kidney damage, and the same autoantibodies found in human SLE.¹⁴

A study of 75 cases found that the disease primarily affects male German Shepherds at an average age of about five years, with joint inflammation in over 90% of cases and kidney involvement in about two-thirds.¹⁵ The sex bias in dogs is actually the reverse of the pattern in humans: canine SLE hits males harder, suggesting that whatever X-chromosome dosage effect drives the human female predisposition works differently, or is overridden by other factors, in dogs. Canine SLE has been used as a natural disease model for studying human lupus, particularly because it arises spontaneously rather than needing to be artificially induced in a lab setting.

Stigma, Visibility, and the Legacy of the Name

The wolf metaphor was never flattering. Medieval descriptions of lupus emphasized horror: flesh being eaten away, faces being destroyed. That legacy of disfigurement-as-identity lingers for patients today, especially those with cutaneous lupus that affects visible skin. A cross-sectional study of 121 people with primary cutaneous lupus, most of them Black women, found that roughly 31% reported moderate to severe depression. The study found that social isolation explained the vast majority of the link between stigma and depression, suggesting that it is not the disease itself but the withdrawal from social life that does the greatest psychological harm.¹⁶

The disease’s very name contributes to a sense of being marked. Being told you have “the wolf” carries a weight that a more neutral clinical label might not. Some patient advocates have called attention to this, arguing that the medieval origin story, with its imagery of flesh-eating wolves, shapes how both patients and the public think about the condition. Whether the name will ever change is another question. Medical terminology is deeply conservative, and “lupus” is now embedded in classification systems, drug labels, and decades of published research. For better or worse, the wolf is staying.